Latest Regulatory News

Page 449 of 900
INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.
Ada Torres
Ada Torres
13 Oct 2025
Eclipse Metals has raised $4 million to accelerate drilling and resource upgrades at its Greenland rare earths project, while preparing for a potential NASDAQ dual listing.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Green Technology Metals has successfully raised A$4.5 million through a two-tranche placement to accelerate development of its Seymour Lithium Project in Ontario, reinforcing its position in the North American lithium sector.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Energy Resources of Australia reported a $47.1 million cash outflow from operations and a $75.4 million investment spend in the September quarter, reducing cash reserves to $108.3 million.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Energy Resources of Australia updates on ongoing legal battles over Jabiluka lease and compulsory acquisition, while Ranger rehabilitation faces delays and potential cost overruns.
Maxwell Dee
Maxwell Dee
13 Oct 2025
ClearVue Technologies has raised A$4.6 million in a strongly supported placement to accelerate international certification and ongoing innovation of its solar façade products.
Victor Sage
Victor Sage
13 Oct 2025
Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Infomedia Limited has received crucial regulatory clearance from the German Federal Ministry for Economic Affairs and Energy for its proposed acquisition by McQueen BidCo, advancing the scheme of arrangement. The company’s board continues to recommend shareholder approval amid remaining conditions.
Sophie Babbage
Sophie Babbage
13 Oct 2025
PYC Therapeutics has reported encouraging pre-clinical results for its RNA therapy candidate PYC-002 targeting Phelan-McDermid Syndrome, supporting plans to enter human trials in 2026. The data demonstrate safety, brain distribution, and gene expression restoration in key disease regions.
Ada Torres
Ada Torres
13 Oct 2025
ENRG Elements Ltd’s EELO securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Immuron Limited reports a robust 34% year-on-year sales increase for Q1 FY26, driven by strong growth in Australia and the USA, while Canadian sales dip seasonally. The company’s marketing efforts and expanding retail presence underpin this momentum.
Ada Torres
Ada Torres
13 Oct 2025
Elementos Limited has executed a binding option agreement to acquire half of Iberian Smelting SL, owner of the Robledollano Tin Smelter in Spain, setting the stage for the EU's first vertically integrated primary tin supply chain.
Maxwell Dee
Maxwell Dee
13 Oct 2025